Zimbabwe has turned down a significant US healthcare agreement valued at $367m (£272m) over five years due to the United States' insistence on sensitive information.
This rejection came to light following a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".
A government spokesperson later stated that the US was seeking genetic material for research and commercial purposes while refused to share the resulting advantages from future vaccines.
"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more talks to reach a agreement suitable to all parties so the country's critical HIV programme can be sustained.
Broader Context
Zimbabwe's decision follows a similar situation in Kenya, where a court blocked a related deal with the US after concerns were raised about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral deals to enhance openness and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided significant benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to surrender its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our country would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our population should a new health crisis arise."
National Interest and Global Health
He also noted that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems previously set up via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This mechanism is designed to guarantee that when a country contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.
"We encourage continued dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the sovereignty and dignity of each country."
Health Experts Response
A leading public health body stated it recognised the official position, but suggested that negotiations must proceed since a large portion of the country's HIV programmes were funded by international support.
"If technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
The situation underscores the complex tensions between accepting much-needed international aid and protecting local interests in an increasingly interconnected world.